Skip to main content
. 2018 Jul 24;17(5):e12822. doi: 10.1111/acel.12822

Table 1.

Demographic, body composition, metabolic, and inflammation markers

Control C (n = 35) Elderly (>70) (n = 28) p value
Sex (n of men (%)) 23 (66.6) 14 (50) 0.193
Age (years) 38.1 ± 0.6 80.8 ± 1.1 <0.001
Weight (kg) 74.8 ± 5.0 70.8 ± 2.5 0.859
BMI 24.4 ± 0.6 27.4 ± 0.6 0.161
Waist‐to‐hip ratio 0.86 ± 0.03 0.92 ± 0.01 0.083
Total body fat (%) 26.3 ± 2.1 37.9 ± 1.4 0.002
Glucose (mmol/L) 4.73 ± 0.15 5.93 ± 0.23 0.048
Insulin (pmol/L) 38.7 ± 8.9 123.8 ± 18.6 0.023
HOMA‐IR 0.45 ± 0.11 1.81 ± 0.28 0.011
Bilirubin (mmol/L) 8.00 ± 1.32 12.69 ± 0.89 0.461
AST (U/L) 28.4 ± 2.6 22.1 ± 1.3 0.579
ALT (U/L) 40.9 ± 8.9 19.2 ± 1.5 0.007
Triglycerides (mmol/L) 1.07 ± 0.21 1.21 ± 0.11 0.856
Total cholesterol (mmol/L) 4.68 ± 0.31 5.08 ± 0.16 0.813
HDL cholesterol (mmol/L) 1.36 ± 0.07 1.33 ± 0.06 0.951
LDL cholesterol (mmol/L) 2.91 ± 0.32 3.17 ± 0.14 0.852
TNFα (pg/ml) 2.91 ± 0.28 4.96 ± 0.61 0.003
MCP−1 (pg/ml) 119.9 ± 7.0 252.1 ± 30.3 <0.001

Parameters are expressed as mean ± SEM unless specified. P values were calculated using Student's t test for parametric data. Bold lettering is shown when p < 0.05.

ALT, alanine transaminase; AST: aspartate transaminase; BMI: body mass index; HDL: high‐density lipoprotein; HOMA‐IR: homeostasis model assessment of insulin resistance; LDL: low‐density lipoprotein; MCP‐1, monocyte chemoattractant protein‐1; TNFα: tumor necrosis factor‐α.